October 20, 2011
Kunihiro Tsukasaki of Nagasaki University (associate professor of the Department of Molecular Medicine and Hematology, Graduate School of Biomedical Sciences) called Kyowa Hakko Kirin’s antibody drug KW-0761 a potentially promising treatment for adult T-cell leukemia/lymphoma (ATL). Prof. Tsukasaki discussed KW-0761...read more